|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2010-2-10
|
|
pubmed:abstractText |
Previous research has identified elevated rates of depressive and anxiety symptoms amongst ecstasy users; however, few studies have examined which factors increase the likelihood of experiencing such symptoms.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1432-2072
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
209
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
25-36
|
|
pubmed:meshHeading |
pubmed-meshheading:20101393-Adolescent,
pubmed-meshheading:20101393-Adult,
pubmed-meshheading:20101393-Affect,
pubmed-meshheading:20101393-Anxiety,
pubmed-meshheading:20101393-Depression,
pubmed-meshheading:20101393-Female,
pubmed-meshheading:20101393-Hallucinogens,
pubmed-meshheading:20101393-Humans,
pubmed-meshheading:20101393-Male,
pubmed-meshheading:20101393-N-Methyl-3,4-methylenedioxyamphetamine,
pubmed-meshheading:20101393-Polymorphism, Genetic,
pubmed-meshheading:20101393-Questionnaires,
pubmed-meshheading:20101393-Risk Factors,
pubmed-meshheading:20101393-Serotonin Plasma Membrane Transport Proteins,
pubmed-meshheading:20101393-Stress, Psychological,
pubmed-meshheading:20101393-Substance-Related Disorders,
pubmed-meshheading:20101393-Young Adult
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Depressive and anxiety symptomatology in ecstasy users: the relative contribution of genes, trauma, life stress and drug use.
|
|
pubmed:affiliation |
School of Psychology and Psychiatry, Monash University, Melbourne, VIC 3800, Australia.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
